Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Immunological Tolerance in Patients With Mismatched Kidney Transplants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from UCLA on inducing immunological tolerance in mismatched kidney transplant recipients with end-stage kidney disease; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: End Stage Kidney Disease, Immunological Tolerance | Phase 1 | Status: ACTIVE_NOT_RECRUITING